-
Diagnostics World | A group of researchers at the University of California Santa Cruz, University of Arizona, and University of Illinois at Chicago have identified a candidate biomarker that may help lead to earlier detection of ovarian cancer without the need for a biopsy. They hope that gynecologists could someday look for the presence of this biomarker while performing a routine Pap smear, but additional research involving more patients is still needed.
Oct 18, 2023
-
Diagnostics World | The rise and fall of blood protein levels over time is an astonishingly good way to assess the risk of major atherosclerotic cardiovascular disease (ASCVD) events such as myocardial infarction (heart attack), as well as an ideal biomarker of the progression of disease and its regression in response to treatment
Oct 17, 2023
-
Diagnostics World | The European Commission (EC), under the EU Merger Regulation (EUMR), released a statement last week announcing it has taken restorative measures that require Illumina to unwind its acquisition of GRAIL. The acquisition was completed before the EC provided approval, breaching EU merger control rules.
Oct 16, 2023
-
Diagnostics World | The laboratory side of diagnostic blood testing has achieved extraordinary efficiency and precision through automation. The last few decades of technology have allowed labs to simplify and automate sample processing to streamline operations and remove opportunities for human error.
Oct 13, 2023
-
Diagnostics World | The feasibility and design of a randomized controlled trial (RCT) for evaluating multi-cancer detection (MCD) assays suited to population-based cancer screening is the aim of a pilot Vanguard Study being undertaken by the National Cancer Institute (NCI).
Oct 10, 2023
-
Diagnostics World | Beginning today, the research team at Children’s Mercy Kansas City is bringing long read sequencing to clinical care, following three years of research and testing of PacBio HiFi sequencing. The transition is expected to speed the diagnostics odyssey for critically ill patients and their families.
Oct 6, 2023
-
Diagnostics World | Soon it may be possible for people to walk into their doctor’s office anywhere in the world and learn from a fingerprick blood sample if they are genetically predisposed to developing osteoporosis. It will matter not if those individuals are anywhere near the age of menopause, or if they’re male or female, because the SNPs being measured were present from the day they were born and men are by no means immune to the condition.
Oct 4, 2023